Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable condition. By delivering intelligent CAD analysis and management insights, Heartflow provides physicians with the clarity and confidence that their next clinical decision is the right one for each individual patient. Heartflow FFRCT is the only non-invasive, lesion-specific FFRCT prospectively validated against invasive gold standards and proven to improve patient outcomes. Heartflow has supported clinicians at over 1,800 institutions in managing more than 600,000 patients worldwide.
